To obtain documents, log on:
:
Not registered? Register me now
 

Public Higher Education Bulletin

 
University of Illinois at Chicago
Exemption #JMG902

Announcement of an Exempt Purchase

Award Info Published Thursday July 29, 2021

McKesson Specialty Care Distribution,Chicago, IL

  • Amount: An estimated $1,680,000
  • Terms: An estimated start date of 8/2/2021 through 6/30/2023
  • Renewals: None

Summary

Vendors

1 total
0 BEP vendors
0 VBP vendors
0 Small businesses

The University award process may be delayed up to thirty days as this award goes through a state approval process.

First published Thursday, July 29, 2021
The University awarded a contract for Abecma.
Abecma (CAR-T therapy) is for treating multiple myeloma.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Abecma is CAR-T therapy for multiple myeloma. It is the only CAR-T therapy commercially available to treat this condition. UI Health currently has several patients who are candidates for Abecma. If this therapy is not made available, these patients will need to seek care at a different institution in order to receive this product.

For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
Jeffrey Walsh
University of Illinois at Chicago
Purchasing Division (M/C 560)
809 South Marshfield Avenue
Chicago, IL 60612-7203
Phone: (312) 355-3568
FAX: (312) 996-3135

The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.

Bulletin Navigation

 
To obtain documents, log on:
Exemption Document
  • JMG902signedMcKessonSpecialtyCareDistribution.pdf (2 MB)